Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2008
12/18/2008US20080312142 Composition for Increasing Body Height
12/18/2008US20080312139 In an injectable form and to be administered through infiltrations inside and around cutaneous chronic ischemic ulcerative wounds as to prevent diabetic limb amputation
12/18/2008US20080312136 Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions
12/18/2008US20080312131 Regeneration of Chromatographic Stationary Phases
12/18/2008US20080312102 Cytokine Binding Domains
12/18/2008US20080312094 Mutated aqp, method for detecting cancer using the same, dna chip having oligonucleotides of said mutated aqp sequence
12/18/2008US20080311675 Dyes having ratiometric fluorescence response for detecting metabolites
12/18/2008US20080311655 Heterodimeric fusion protein for use in the treatment of allergies and metastatic disease; cytokine linked to an antibody; nucleic acid encoding a fusion protein comprising an immunoglobulin (Ig) moiety linked by a peptide bond to the p35 subunit of interleukin-12
12/18/2008US20080311654 Effective as an anti-differentiator while the chicken differentiable cell is being cultured; enables stable supply of the LIF protein derived from chickens
12/18/2008US20080311652 Nucleic acids encoding Melanoma-associated antigen C2 (MAGE-C2); for provoking a cytolytic T cell response; for determining if a cell presents a Human Leukocyte Antigen(HLA) molecule on its surface; diagnostic and therapeutic assays; tumor monitoring
12/18/2008US20080311624 Chimeric immunogens
12/18/2008US20080311622 Activatable recombinant neurotoxins
12/18/2008US20080311621 Polypeptides and nucleic acids encoding same
12/18/2008US20080311620 Novel Genes
12/18/2008US20080311618 Expression System, Components Thereof and Methods of Use
12/18/2008US20080311608 Antagonist of the oncogenic activity of the protein MDM2, and use thereof in the treatment of cancers
12/18/2008US20080311597 Modified Cardiolipin and Uses Therefor
12/18/2008US20080311594 USE OF FIBROBLAST GROWTH FACTOR 7 (Fgf7) AND OF THE RECEPTOR Fgfr2b AS BIOMARKERS
12/18/2008US20080311588 nucleotide sequences coding transcription factor for use as regulatory tools in nervous system development; Protein/transcription factor in basic-helix-loop-helix (bHLH) gene family which plays role in cell determination; genetic engineering
12/18/2008US20080311584 desirable for identification of animals having or having a predisposition for increased muscle mass that can be used to produce food products, including bovine, porcine, ovine, avian and piscine species; influence hypertrophic and hyperplastic muscle development
12/18/2008US20080311580 Novel genes encoding proteins involved in proanthocyanidin synthesis
12/18/2008US20080311154 Cold-adapted equine influenza viruses
12/18/2008US20080311151 Vaccine For Periodontal Disease
12/18/2008US20080311150 Novel sequences encoding hepatitis C virus glycoproteins
12/18/2008US20080311149 DNA-transfection system for the generation of infectious influenza virus
12/18/2008US20080311148 DNA-transfection system for the generation of infectious influenza virus
12/18/2008US20080311146 Immunogenic Composition
12/18/2008US20080311144 Mutant forms of cholera holotoxin as an adjuvant
12/18/2008US20080311138 Adjuvant Activity of Gastrointestinal Peptides
12/18/2008US20080311137 Carcinoembryonic Antigen Fusions and Uses Thereof
12/18/2008US20080311133 Methods of using multivalent mhc class ii-peptide chimeras
12/18/2008US20080311132 Human Complement C3 Derivates with Cobra Venom Factor-Like Function
12/18/2008US20080311131 Human Mob-5 (IL-24) receptors and uses thereof
12/18/2008US20080311130 Integrin Alpha L I Domain Mutants with Increased Binding Affinity
12/18/2008US20080311125 Scytovirin Domain 1 Related Polypeptides
12/18/2008US20080311124 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders
12/18/2008US20080311123 Compositions and methods for the therapy and diagnosis of breast cancer
12/18/2008US20080311120 Autocrine growth factor receptor antibodies and methods
12/18/2008US20080311118 Vascular endothelial cell growth factor antagonists and uses thereof
12/18/2008US20080311116 Process for the Determination of Inflammatory Process and Pharmaceutical Compositions for the Treatment Thereof
12/18/2008US20080311110 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease
12/18/2008US20080311109 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders
12/18/2008US20080311108 Polypeptides
12/18/2008US20080311106 Product Comprising a C4bp Core Protein and a monomeric Antigen, and Its Use
12/18/2008US20080311073 Ilt3 Polypeptides and Uses Thereof
12/18/2008US20080311051 Caspase-2 Inhibitors And Their Biological Applications
12/18/2008US20080311042 Loop-Variant Pdz Domains as Biotherapeutics, Diagnostics and Research Reagents
12/18/2008DE19509881B4 Ovoglycoprotein und dasselbe enthaltende Agens für chromatografische Aufspaltung Ovoglycoprotein and containing the same agent for chromatographic splitting
12/18/2008DE102004007658B4 Verfahren zur Herstellung von rekombinanten Proteinen in eukaryontischen Wirtszellen A process for the production of recombinant proteins in eukaryotic host cells
12/18/2008CA2840407A1 Compositions and methods for producing bioactive fusion proteins
12/18/2008CA2692019A1 Cell-proliferation inhibiting vpg proteins, fragments or analogs thereof and their applications
12/18/2008CA2690905A1 Recombinant transferrin mutants
12/18/2008CA2690764A1 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
12/18/2008CA2690267A1 Small cationic antimicrobial peptides
12/18/2008CA2689913A1 Rtef-1 variants and the use thereof for inhibition of angiogenesis
12/18/2008CA2689492A1 Natriuretic fusion proteins
12/18/2008CA2689050A1 Rumc peptides with antimicrobial activity
12/18/2008CA2688265A1 Selective cell therapy for the treatment of renal failure
12/18/2008CA2687896A1 Inhibitors of receptor tyrosine kinases and methods of use thereof
12/18/2008CA2687746A1 Methods of treating, diagnosing and detecting fgf21-associated disorders
12/18/2008CA2687141A1 Compositions and methods for producing bioactive fusion proteins
12/18/2008CA2684780A1 Formation of proteoliposomes containing membrane proteins by means of an acellular protein synthesis system
12/18/2008CA2683287A1 Novel glycosylated peptide target in neoplastic cells
12/18/2008CA2667788A1 Staphylococcus aureus specific anti-infectives
12/17/2008EP2003451A2 T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
12/17/2008EP2003205A2 Improved grain quality through altered expression of seed proteins
12/17/2008EP2003203A1 Ligand for receptor activator of nf-kappa b, ligand is member of TNF superfamily
12/17/2008EP2003202A2 G protein-coupled receptor up-regulated in prostate cancer and uses thereof
12/17/2008EP2003201A2 Compounds and methods for therapy and diagnosis of lung cancer
12/17/2008EP2003200A1 Phage display by novel filamentous bacteriophage
12/17/2008EP2003145A2 Protein stabilizing agent
12/17/2008EP2003144A1 Method for the diagnosis or the screening of an arbovirus infection, reagents useful in said method and their applications
12/17/2008EP2003143A1 Cell-proliferation inhibiting VPg proteins, fragments or analogs thereof and their applications
12/17/2008EP2002259A2 Disheveled pdz modulators
12/17/2008EP2002005A1 Identification of crmp4 as a convergent regulator of axon outgrowth inhibition
12/17/2008EP2001907A2 Methods and compositions for antagonism of rage
12/17/2008EP2001905A1 Expression, secretion and purification of recombinant bovine serum albumin (rbsa) and uses thereof
12/17/2008EP2001904A2 Proteins, nucleic acids and medicaments
12/17/2008EP2001903A2 Long-acting polypeptides and methods of producing and administering same
12/17/2008EP2001902A1 Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cells
12/17/2008EP2001901A2 Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
12/17/2008EP2001900A2 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
12/17/2008EP2001899A1 Peptides against autoantibodies associated with glaucoma and use of these peptides
12/17/2008EP2001459A2 Methods and compositions for inducing an immune response to hiv and models for testing
12/17/2008EP1763334B1 Keratin-binding polypeptides
12/17/2008EP1614426B1 Attenuated strains of vibrio cholerae and lyophilised vaccines containing same
12/17/2008EP1572889B1 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
12/17/2008EP1540016B1 METHOD FOR DETERMINING THE ALLELIC STATE OF THE 5'-END OF THE alpha-S1-CASEIN GENE
12/17/2008EP1530592B1 Chimeric mhc protein and oligomer thereof
12/17/2008EP1230214B1 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
12/17/2008EP1144607B1 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds
12/17/2008EP1024829B1 Tolerogenic fragments of natural allergens
12/17/2008EP1007696B1 Il-13 receptor specific chimeric proteins and uses thereof
12/17/2008EP1007673B1 Novel bone mineralization proteins, dna, vectors, expression systems
12/17/2008EP0966297B1 Regulation of gastrointestinal motility
12/17/2008EP0909317B1 Compositions for modulating the length of telomeres
12/17/2008EP0791067B1 Protein kinase npk-110
12/17/2008CN101326271A Use of proteins as an antifoaming constituent in fuels
12/17/2008CN101326194A Polynucleotides encoding phenylpropanoid pathway enzymes in coffee
12/17/2008CN101323856A White clover Na+/H- antiport protein gene TrNHX1, encoding protein and use thereof